Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pharmacy Service, Hospital | 1 | 2016 | 9 | 0.510 |
Why?
|
| Anesthesia, Inhalation | 1 | 2016 | 16 | 0.510 |
Why?
|
| Anesthetics, Inhalation | 1 | 2016 | 17 | 0.510 |
Why?
|
| Volatile Organic Compounds | 1 | 2016 | 7 | 0.510 |
Why?
|
| Cost Savings | 1 | 2016 | 35 | 0.500 |
Why?
|
| Hospital Costs | 1 | 2016 | 49 | 0.500 |
Why?
|
| Anesthesiology | 1 | 2016 | 48 | 0.480 |
Why?
|
| Postoperative Complications | 3 | 2020 | 828 | 0.280 |
Why?
|
| Enzymes, Immobilized | 1 | 2006 | 4 | 0.260 |
Why?
|
| Silicon Dioxide | 1 | 2006 | 10 | 0.260 |
Why?
|
| Nanocomposites | 1 | 2006 | 6 | 0.260 |
Why?
|
| Polyamines | 1 | 2006 | 11 | 0.250 |
Why?
|
| Drug Compounding | 1 | 2006 | 36 | 0.250 |
Why?
|
| Hypotension | 1 | 2020 | 48 | 0.160 |
Why?
|
| Dantrolene | 1 | 2019 | 2 | 0.150 |
Why?
|
| Malignant Hyperthermia | 1 | 2019 | 4 | 0.150 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 2019 | 5 | 0.150 |
Why?
|
| Muscle Relaxants, Central | 1 | 2019 | 6 | 0.150 |
Why?
|
| Succinylcholine | 1 | 2019 | 6 | 0.150 |
Why?
|
| Intubation, Intratracheal | 2 | 2009 | 74 | 0.150 |
Why?
|
| Aspirin | 1 | 2016 | 62 | 0.130 |
Why?
|
| Venous Thromboembolism | 1 | 2016 | 28 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 69 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2016 | 56 | 0.120 |
Why?
|
| Ischemic Preconditioning | 1 | 2015 | 2 | 0.120 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2015 | 9 | 0.120 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2015 | 18 | 0.120 |
Why?
|
| Creatinine | 1 | 2015 | 198 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 81 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2016 | 324 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2020 | 3701 | 0.090 |
Why?
|
| Lighting | 1 | 2009 | 4 | 0.080 |
Why?
|
| Humans | 9 | 2020 | 32798 | 0.080 |
Why?
|
| Gagging | 1 | 2009 | 1 | 0.080 |
Why?
|
| Lidocaine | 1 | 2009 | 19 | 0.080 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2006 | 3 | 0.070 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2006 | 10 | 0.060 |
Why?
|
| Enzyme Stability | 1 | 2006 | 6 | 0.060 |
Why?
|
| Dendrimers | 1 | 2006 | 3 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 94 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2020 | 1844 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2006 | 97 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2020 | 3438 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 2006 | 233 | 0.060 |
Why?
|
| Risk Factors | 2 | 2020 | 3974 | 0.040 |
Why?
|
| Aged | 3 | 2020 | 10538 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 4032 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 34 | 0.040 |
Why?
|
| Anemia | 1 | 2020 | 57 | 0.040 |
Why?
|
| Oxygen | 1 | 2020 | 144 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2020 | 59 | 0.040 |
Why?
|
| Female | 4 | 2020 | 20261 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 369 | 0.030 |
Why?
|
| Heart Valves | 1 | 2015 | 16 | 0.030 |
Why?
|
| Male | 3 | 2020 | 19641 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2016 | 78 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 467 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2015 | 195 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 57 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2015 | 111 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 2327 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 1460 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 532 | 0.030 |
Why?
|
| Middle Aged | 2 | 2020 | 12125 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 2730 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 3638 | 0.020 |
Why?
|
| Glossopharyngeal Nerve | 1 | 2009 | 1 | 0.020 |
Why?
|
| Fiber Optic Technology | 1 | 2009 | 15 | 0.020 |
Why?
|
| Wakefulness | 1 | 2009 | 26 | 0.020 |
Why?
|
| Nerve Block | 1 | 2009 | 50 | 0.020 |
Why?
|
| Anesthetics, Local | 1 | 2009 | 81 | 0.020 |
Why?
|
| Immunodominant Epitopes | 1 | 2006 | 2 | 0.020 |
Why?
|
| H-2 Antigens | 1 | 2006 | 7 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2006 | 9 | 0.020 |
Why?
|
| Adult | 1 | 2020 | 9560 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2006 | 21 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2006 | 59 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 169 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 282 | 0.020 |
Why?
|
| Mice | 1 | 2006 | 2511 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 7569 | 0.010 |
Why?
|